Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituE. Shelley Hwang, Doreen M. Agnese, Meredith Witten et al.|JAMA|2024Cited by 75
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In SituAnn H. Partridge, Kimberly Strickland, Terry Hyslop et al.|JAMA Oncology|2024Cited by 16
Abstract GS2-06: Patient Reported Outcomes Following Active Monitoring or Surgery (+/- Radiation) for Low Risk DCIS in the Comparing an Operation to Monitoring, with or without Endocrine Therapy (COMET) Study (AFT-25)Ann H. Partridge, Shelley Hwang, Terry Hyslop et al.|Clinical Cancer Research|2025Cited by 0